- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05058521
Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study)
Venous Thromboembolism Risk Profiles Among Hospitalized Patients in Chinese General Hospital- a Cross-sectional Single-institution Based Study
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
In this study, the investigators recruited adult inpatients attending Tsinghua Chang Gung Hospital in Beijing from June 2018 to April 2020, screened for patients with a hospital stay over 3 days and new-onset of VTE during hospital stay, and identified the in-hospital VTE patients after excluding patients who presented for DVT and/or PE. Similarly, negative patients were selected by not having a VTE during hospital stay. The diagnosis of VTE was confirmed as the occurrence of a critical value alert during hospitalization, which was predefined as ultrasound/radiology report of DVT or/and PE. Data was collected from the TEACH database of Beijing Tsinghua Chang Gung Hospital affiliated with Tsinghua University.
Patients baseline characteristics were extracted from database. VTE risk assessment was conducted with either Caprini risk assessment model (surgical patients) or Padua prediction score (medical patients). The evaluation was started upon admission and regularly repeated depending on the patient's condition. The last evaluation was conducted before discharge. The D-dimer values during hospitalization were also collected.
The rate of in-hospital VTE, distributions of in-hospital VTE patients and the receiver operating characteristic curves were analyzed.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Beijing, Kina, 102218
- Beijing Tsinghua Chang Gung Hosipital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Age 18 and over, male or female
- Inpatients with a hospital stay over 3 days
- With or without new-onset of VTE during their stay
Exclusion Criteria:
- Patients who presented for DVT and/or PE
- Patients who were admitted in emergency department
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
---|
In-hospital VTE group
In-hospital VTE group includes patients who were with a hospital stay over 3 days and new-onset of VTE during their stay.
Patients who presented for VTE were excluded.
|
Negative group
Negative group includes patients who were with a hospital stay over 3 days and did not have a VTE during their hospital stay.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
The rate of in-hospital VTE
Tidsram: From June 2018 to April 2020
|
The diagnosis of VTE was confirmed as the occurrence of a critical value alert during hospitalization, which was predefined as ultrasound/radiology report of DVT or/and PE.
|
From June 2018 to April 2020
|
Caprini risk assessment model scores
Tidsram: Through discharge, an average of 20 days
|
Patients were stratified of VTE risk as very low risk (0), low risk (1-2), medium risk (3-4), high risk (5 and over).
|
Through discharge, an average of 20 days
|
Padua prediction score scores
Tidsram: Through discharge, an average of 20 days
|
Patients were stratified of VTE risk as low risk (0-3) and high risk (4 and over).
|
Through discharge, an average of 20 days
|
D-dimer values
Tidsram: Through discharge, an average of 20 days
|
The upper normal value 0.55mg/L FEU was used.
|
Through discharge, an average of 20 days
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Weiwei Wu, MD, Beijing Tsinghua Chang Gung Hospital
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 19242-4-01
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Venös tromboembolism
-
South Tyneside and Sunderland NHS Foundation TrustOkändCentral Venous Cather PositionStorbritannien
-
Genentech, Inc.AvslutadDysfunctional Central Venous Access Devices (CVADS)
-
B.Braun Médical - CoE ChasseneuilHar inte rekryterat ännuPrestanda/säkerhet hos Celsite® Venous Access Ports
-
Peking Union Medical College HospitalAvslutad
-
Ji Xunming,MD,PhDRekryteringCerebral Venous Sinus TrombosKina
-
University Hospital, AkershusUniversity of Oslo; Oslo University Hospital; Rigshospitalet, Denmark; University... och andra samarbetspartnersRekryteringCerebral Ven Trombos | Cerebral Venous Sinus TrombosNorge
-
Peking Union Medical College HospitalAvslutadAkut njurskada | Njurartärblodflöde | Renal Venous Return | Renal mikrocirkulationKina
-
Capital Medical UniversityOkändCerebral Venous Sinus Trombos | BatroxobinKina
-
Second Affiliated Hospital, School of Medicine,...RekryteringMagnetisk resonanstomografi | Cerebral Venous Sinus Trombos | DatortomografiKina
-
Capital Medical UniversityThe First Affiliated Hospital of Zhengzhou University; Guizhou Provincial... och andra samarbetspartnersAvslutadCerebral Ven Trombos | Cerebral Venous Sinus TrombosKina